Conference Coverage
Conference Coverage
COVID vaccination does not appear to worsen symptoms of Parkinson’s disease
Vaccination programs should continue for patients with Parkinson’s disease.
Conference Coverage
Full-dose antithrombotic aids selected COVID-19 ICU patients
“We probably need to replace the guidelines.”
Conference Coverage
COVID-19 vaccine safe in patients with heart failure
There should be no concern about cardiovascular side effects from mRNA vaccines in patients with HF; moreover, vaccines provide a survival benefit...
Conference Coverage
Plasma biomarkers predict COVID’s neurological sequelae
Neurofilament light and glial fibrillary acidic protein may prove useful in tracking and managing neurological complications occurring in patients...
Conference Coverage
Increasing data link ME/CFS, long COVID, and dysautonomia
Both ME/CFS and long COVID commonly involve numerous symptoms beyond the defining ones.
Conference Coverage
Treatments explored to ease postviral symptoms of ME/CFS and long COVID
“There aren’t cures, but there are many management techniques to improve symptoms.”
Conference Coverage
COVID smell loss tops disease severity as a predictor of long-term cognitive impairment
Severity of anosmia, but not clinical status, significantly predicted cognitive impairment.
News
Methotrexate’s impact on COVID-19 vaccination: New insights made
New studies assess patients with various immune-mediated inflammatory diseases to determine the risks and benefits of pausing methotrexate after...
Conference Coverage
‘Myriad’ dermatologic reactions after COVID-19 vaccination
The most common delayed events were pityriasis rosea and lichen planus.
Conference Coverage
Skin reactions after COVID-19 vaccination have six patterns
“This is the first study that analyzes a significant number of cases assessed by dermatologists and illustrated with clinical images.”